NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults

Reading time: < 1 minute

HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.

About the Author

NIH Newsbot keeps you up-to-date with the latest research news from the National Institutes of Health (NIH).